Province, China

Liu Yang

This inventor holds 1 USPTO granted patent. Top assignees: China Medical University Hospital, The University of North Carolina at Chapel Hill. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liu Yang. Retrieved from https://idiyas.com/inventor/liu-yang-3rbudv20

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 21.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Liu Yang - Innovator in Antitumor Agents

Introduction

Liu Yang is a notable inventor based in Province, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antitumor agents.

Latest Patents

Liu Yang holds 1 patent related to novel 20-sulfonylamidine derivatives of camptothecin. This invention includes a method of synthesizing these derivatives and their use as an antitumor agent, specifically for treating nasopharyngeal, lung, breast, or prostate cancer.

Career Highlights

Throughout his career, Liu Yang has worked at prestigious institutions such as China Medical University Hospital and the University of North Carolina at Chapel Hill. His work has focused on advancing cancer treatment through innovative chemical compounds.

Collaborations

Liu has collaborated with esteemed colleagues, including Kuo-Hsiung Lee and Keduo Qian, who have contributed to his research endeavors.

Conclusion

Liu Yang's innovative work in developing antitumor agents showcases his commitment to improving cancer treatment options. His contributions to medicinal chemistry are noteworthy and continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…